Experience

• 

  Washington State Department of Health

  • Epidemiologist II

    • Nov 2022 - Present
• 

  Baltimore City Health Department

  • United States
  • Government Administration
  • 400 - 500 Employee

  • Epidemiologist

    • Feb 2022 - Oct 2022

    Seconded from Jhpiego to the BCHD COVAX program under the VALUE Communities project, a project aimed at improving COVID-19 vaccine access, acceptance, and uptake amongst Baltimore’s most vulnerable populations.• Serves as point of contact person for VALUE communities epidemiology work. Oversees, develops, and implements complex COVID vaccine epidemiology work, including the coordination of epidemiological efforts with multi-disciplinary teams.• Develops methods for and conducts advanced descriptive and comprehensive analyses (regression modeling, etc.) of vaccine clinic data.• Evaluates the efficiency and effectiveness of programs.• Continues all duties from prior data analyst role.

  • Data Analyst

    • May 2021 - Jan 2022

    • Produce weekly report summarizing COVID-19 vaccination data from BCHD-involved vaccination clinics using reproducible code that I wrote/developed in R.• Took initiative to code, publish, and update weekly an R Shiny online dashboard that visually displays COVID-19 vaccination clinic and outreach data and allows users to manipulate figures using built-in input panel, improving real-time utilization of data. • Oversaw design of two surveys to track vaccination outreach efforts by ambassadors and canvassers. Manage surveys in Google Forms, produce weekly PDF summary reports of each in R, and incorporate data into R Shiny web application described above.• Maps locations of clinics weekly using ArcGIS Online software.• Assists with REDCap database maintenance activities including: updating records, adding form fields, importing data files, and creating new instruments. Extracts clinic data from REDCap for analysis for clinic report/dashboard described above.• Presents report and dashboard data at weekly meetings and interprets key findings to help inform strategy changes/decisions and track progress towards vaccine targets.

• 

  Johns Hopkins Bloomberg School of Public Health...

  • Baltimore, Maryland, United States

  • Research Assistant

    • May 2020 - May 2021
    • Baltimore, Maryland, United States

    Student assistant on cholera dynamics project, a project aimed at characterizing cholera transmission dynamics, global cholera burden, and estimated impact of cholera interventions including the oral cholera vaccine. • Audited names of locations with reported cholera cases to validate existence a...

• 

  The Johns Hopkins University School of Medicine...

  • Baltimore, Maryland, United States

  • Post-Baccalaureate Fellow

    • Jul 2017 - Aug 2019
    • Baltimore, Maryland, United States

    Performed research characterizing novel small therapeutic agents for inflammatory bowel disease (IBD); a disease with increasing worldwide prevalence for which current therapeutics are largely ineffective.• Maintained/bred colonies of genetically-modified mice for use in a murine colitis model • ...

• 

  University of North Carolina at Chapel Hill School of Medicine

  • United States
  • Higher Education
  • 700 & Above Employee

  • Undergraduate Research Assistant

    • Aug 2016 - May 2017

    Conducted genomic research at the Infectious Disease, Epidemiology, and Ecology Lab on copy number variations that cause resistance to the drug piperaquinein in the malaria inducing parasite, Plasmodium falciparum. Ran qPCRs, ddPCRs, and gel electrophoresis to analyze 100+ clinical DNA samples.

  • Undergraduate Research Assistant

    • Aug 2016 - Apr 2017

    Volunteer with UNC Urogynecology; assisted on a chart-based research project measuring the sacral anatomy of 180 patients who underwent Interstim surgery to treat urinary incontinence

• 

  National Institutes of Health

  • Bethesda, MD

  • Amgen Scholar

    • Jun 2016 - Aug 2016
    • Bethesda, MD

    • In Rick Fairhurst's lab at NIAID, charted the life cycle of mutant and WT Plasmodium-falciparum malaria by counting the number of parasites in each life stage for eight complete life cycles• Cultured five field isolates from Cambodia and Mali until they reached 5% parasitemia and performed ...